Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study

Ann Intern Med. 2021 Jan;174(1):137-138. doi: 10.7326/M20-1468. Epub 2020 Sep 8.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Antiviral Agents / therapeutic use*
  • Female
  • Hepacivirus / immunology*
  • Hepatitis C Antibodies / immunology*
  • Hepatitis C, Chronic / prevention & control*
  • Hepatitis C, Chronic / virology
  • Humans
  • Kidney Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Tissue Donors*

Substances

  • Antiviral Agents
  • Hepatitis C Antibodies